0 Комментарии
0 Поделились
153 Просмотры
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
GLP-1 Agonists Weight Loss Drugs Market Analysis 2025–2030The global GLP-1 agonists weight loss drugs market size was estimated at USD 13.84 billion in 2024 and is projected to reach USD 48.84 billion by 2030, growing at a CAGR of 18.54% from 2025 to 2030. The rapid expansion of this market is largely fueled by the increasing prevalence of obesity worldwide, heightened public awareness about health and wellness, and the proven clinical...0 Комментарии 0 Поделились 1Кб Просмотры
-
GLP-1 Analogues Market Size, Share, Trends & Forecast to (2024-2032) | UnivDatosAccording to the UnivDatos, the rising prevalence of type 2 diabetes and obesity, innovations such as oral formulations and long-acting drugs, increased patient awareness, and regulatory approvals drive the GLP-1 Analogues market. As per their “GLP-1 Analogues Market” report, the global market was valued at USD 37 Billion in 2023, growing at a CAGR of about 28% during the forecast...0 Комментарии 0 Поделились 2Кб Просмотры
-
GLP-1 Market Growth Catalyst: Key Drivers Accelerating DemandPolaris Market Research has published a new report titled GLP-1 Market Size, Share, & Industry Analysis Report: By Route of Administration (Oral and Parenteral), By Type of Molecule, By Active Compound Used, By Type of GLP-1 Agonist Drug, By Target Indication, and By Region – Market Forecast, 2025–2034 that delivers up-to-date analysis with analyses of the current and future...0 Комментарии 0 Поделились 43 Просмотры
-
GLP-1 Market Positioned for Exceptional Growth by 2034Polaris Market Research has announced the latest report, namely GLP-1 Market Size, Share, & Industry Analysis Report: By Route of Administration (Oral and Parenteral), By Type of Molecule, By Active Compound Used, By Type of GLP-1 Agonist Drug, By Target Indication, and By Region – Market Forecast, 2025–2034, that examines the overall market condition both now and in the future....0 Комментарии 0 Поделились 237 Просмотры
-
GLP-1 Nutritional Support Market Transformation with Telehealth IntegrationThe GLP-1 nutritional support market is entering a new growth phase, with rising adoption across clinical, consumer, and telehealth channels. From a projected value of USD 4.1 billion in 2025, the market is forecast to expand to USD 13 billion by 2035, advancing at a 12.2% CAGR. This expansion is closely tied to the global uptake of GLP-1 therapies for diabetes and weight management,...0 Комментарии 0 Поделились 1Кб Просмотры
-
GLP-1 Receptor Agonist Market Forecasted for Steady and Robust Growth by 2034A new growth forecast report titled GLP-1 Receptor Agonist Market Size, Share, & Industry Analysis Report: By Route of Administration (Parenteral and Oral), By Product, By Application, By Distribution Channel, and By Region – Market Forecast, 2025–2034 introduced by Polaris Market Research represents conclusive data on the overall market. It majorly targets to provide...0 Комментарии 0 Поделились 489 Просмотры
-
Obesity GLP-1 Market Growth, Industry & Landscape Outlook, Revenue Analysis By FMIFuture Market Insights (FMI), a leading provider of market intelligence and consulting services, today released its comprehensive report on global obesity GLP-1 market is poised for transformative expansion, surging from USD 8,169 million in 2025 to an estimated USD 65,364 million by 2035. This represents an extraordinary absolute increase of USD 57,195 million, translating to 700%...0 Комментарии 0 Поделились 140 Просмотры
-
Strategic Approvals and Pipeline Advances Accelerate the GLP-1 Receptor Agonist MarketPolaris Market Research has published a brand-new report titled GLP-1 Receptor Agonist Market Size, Share, & Industry Analysis Report: By Route of Administration (Parenteral and Oral), By Product, By Application, By Distribution Channel, and By Region – Market Forecast, 2025–2034 that includes extensive information and analysis of the industry dynamics. The...0 Комментарии 0 Поделились 351 Просмотры
-
Polycystic Ovary Syndrome (PCOS) Treatment Market Trend AnalysisIntrospective Market Research (IMR) announces a comprehensive analysis of the Global Polycystic Ovary Syndrome (PCOS) Treatment Market. PCOS, a complex endocrine disorder affecting reproductive-aged women, is a major driver in the women's health sector due to its lifelong implications for metabolic health and fertility. The market, valued at USD 1.5 Billion in 2023, is projected to witness...0 Комментарии 0 Поделились 2Кб Просмотры
Расширенные страницы
© 2026 Scenario.press - libera espressione
Russian
Russian
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek